Webinar Series: Web Brief -- UltraMAB, the Ultra-specific Antibody

Posted by

amsbio

This video introduces a breakthrough technology -- High-density Protein Microarray -- that can be used to test the specificity of an antibody. It has been proved that some commonly used diagnostic monoclonal antibodies on the market are not specific to their targets. Utilizing this technology and the capacity of monoclonal antibody generation, OriGene has successfully developed the ultra-specific antibody against HER2 for breast cancer, as well as many other cancer biomarkers. Find out more http://www.amsbio.com/truemab.aspx